Method for preventing and/or treating insulin resistance

M. Nieuwdorp (Inventor), W.M. de Vos (Inventor)

Research output: PatentOther research output

Abstract

The present invention describes use of Eubacterium hallii et rel. and/or Alcaligenes faecalis et rel., as well as pharmaceutical, food, or feed compositions comprising these bacteria, as a medicament, in particular for preventing and/or treating insulin resistance and/or insulin resistance-related complications such as metabolic syndrome, dyslipidemia and type 2 diabetes mellitus as well as insulin resistance in endocrine diseases (e.g.,obese subjects with type 1 diabetes mellitus, Cushing's disease and lipodystrophy syndromes. Also described is a method for preventing and/or treating insulin resistance and/or insulin resistance-related complications such as dyslipidemia and type 2 diabetes mellitusas well as insulin resistance in endocrine diseases (e.g.,obese subjects with type 1 diabetes mellitus, Cushing's disease and lipodystrophy syndromes)in a subject in need thereof, said method comprising the step of increasing the level of Eubacterium hallii et rel. and/or Alcaligenes faecalis et rel. in the small intestine
Original languageEnglish
Patent numberWO2013032328
Priority date31/08/11
Publication statusPublished - 7 Mar 2013

Fingerprint Dive into the research topics of 'Method for preventing and/or treating insulin resistance'. Together they form a unique fingerprint.

Cite this